日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Patient-Reported Symptoms and Quality of Life With Sacituzumab Govitecan Versus Docetaxel in Metastatic NSCLC: The Phase 3, Randomized EVOKE-01 Trial

Sacituzumab Govitecan 与多西他赛治疗转移性非小细胞肺癌的患者报告症状和生活质量:3 期随机 EVOKE-01 试验

Reinmuth, Niels; Couraud, Sébastien; Paz-Ares, Luis; Garassino, Marina Chiara; Baijal, Shobhit; Daniel, Davey; Garrido, Pilar; Kato, Terufumi; Percent, Ivor; Rittmeyer, Achim; Parra, Hector Soto; Mekan, Sabeen; Patel, Mira; Radford, Matthew; Zhang, Eric; Pelligra, Christopher G; Guo, Shien; Felip, Enriqueta

Clinical Concordance of Pan Lung Cancer PCR Panel Covering 167 Actionable Variants Across 11 Genes and Other Validated Assays in the LC-SCRUM-Asia Registry

LC-SCRUM-Asia 注册研究中,涵盖 11 个基因中 167 个可操作变异的泛肺癌 PCR 检测与其他已验证检测方法的临床一致性

Matsumoto, Shingo; Seto, Takashi; Svedman, Christer; Kato, Terufumi; Nishino, Kazumi; Furuya, Naoki; Ohe, Yuichiro; Toyozawa, Ryo; Kodani, Masahiro; Shingyoji, Masato; Shibata, Yuji; Nosaki, Kaname; Izumi, Hiroki; Zenke, Yoshitaka; Murata, Yuri; Yoh, Kiyotaka; Goto, Koichi

Local control of locally advanced uterine sarcoma achieved by cervical brachytherapy with gel spacer following cyclic hypofractionated radiation therapy (QUAD shot) in a patient who refused surgery

对于拒绝手术的局部晚期子宫肉瘤患者,在接受周期性低分割放射治疗(QUAD shot)后,采用凝胶间隔物进行宫颈近距离放射治疗,实现了局部控制。

Kosugi, Yasuo; Murakami, Naoya; Karino, Tatsuki; Muramoto, Yoichi; Kawamoto, Terufumi; Oshima, Masaki; Okonogi, Noriyuki; Saito, Anneyuko I; Takatsu, Jun; Inoue, Tatsuya; Iijima, Kotaro; Hashizume, Akane; Tomita, Shigeki; Kato, Masaya; Ujihira, Takafumi; Makino, Shintaro; Hirayama, Takashi; Fujino, Kazunari; Terao, Yasuhisa; Shikama, Naoto

First-Line Mobocertinib Versus Platinum-Based Chemotherapy in Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer in the Phase III EXCLAIM-2 Trial

在III期EXCLAIM-2试验中,一线Mobocertinib与铂类化疗在EGFR 20号外显子插入阳性转移性非小细胞肺癌患者中的疗效比较

Jänne, Pasi A; Wang, Bin-Chao; Cho, Byoung Chul; Zhao, Jun; Li, Juan; Hochmair, Maximilian; Peters, Solange; Besse, Benjamin; Pavlakis, Nick; Neal, Joel W; Kato, Terufumi; Wu, Yi-Long; Nguyen, Danny; Lin, Junjing; Lin, Jianchang; Vranceanu, Florin; Szumski, Annette; Lin, Huamao M; Fram, Robert J; Mok, Tony S K

An SNP-dependent cancer-testis antigenic epitope serves as a promising immunotherapeutic target for cancer

一种依赖于单核苷酸多态性(SNP)的癌睾丸抗原表位是癌症免疫治疗的一个有前景的靶点。

Murata, Kenji; Minowa, Tomoyuki; Tsukahara, Tomohide; Yoshida, Taku; Minami, Akiko; Nakatsugawa, Munehide; Mizue, Yuka; Murai, Aiko; Tokita, Serina; Sasaki, Kenta; Uhara, Hisashi; Kubo, Terufumi; Kanaseki, Takayuki; Torigoe, Toshihiko; Hirohashi, Yoshihiko

Development of a T cell engaging bispecific antibody targeting long non-coding RNA PVT1

开发一种靶向长链非编码RNA PVT1的T细胞结合双特异性抗体

Kato, Hirotaka; Tsukahara, Tomohide; Murata, Kenji; Nishikata, Hiromu; Mizue, Yuka; Sasaya, Takashi; Kubo, Terufumi; Kanaseki, Takayuki; Hirohashi, Yoshihiko; Oyagi, Atsushi; Maeda, Tatsuo; Miyazaki, Akihiro; Torigoe, Toshihiko

KEYNOTE-A17: First-Line Pembrolizumab Plus Cisplatin-Pemetrexed in Japanese Participants With Advanced Pleural Mesothelioma

主题演讲-A17:一线帕博利珠单抗联合顺铂-培美曲塞治疗日本晚期胸膜间皮瘤患者

Kijima, Takashi; Kato, Terufumi; Goto, Yasushi; Kuribayashi, Kozo; Mikami, Koji; Negi, Yoshiki; Murakami, Shuji; Yoshida, Tatsuya; Homma, Masae; Wakana, Akira; Noguchi, Kazuo; Fujimoto, Nobukazu

The size of CD8+ infiltrating T cells is a prognostic marker for esophageal squamous cell carcinoma

CD8+浸润T细胞的数量是食管鳞状细胞癌的预后标志物。

Shigehara, Kengo; Kawai, Noriko; Shirosaki, Tomohide; Ebihara, Yuma; Murai, Aiko; Takaya, Akari; Tokita, Serina; Sasaki, Kenta; Shijubou, Naoki; Kubo, Terufumi; Murata, Kenji; Kanaseki, Takayuki; Tsukahara, Tomohide; Hatanaka, Yutaka; Mitsuhashi, Tomoko; Shichinohe, Toshiaki; Hirohashi, Yoshihiko; Hirano, Satoshi; Torigoe, Toshihiko

SARS-CoV-2 infection promotes lung thrombosis by inducing integrinβ3 expression in vascular endothelial cells

SARS-CoV-2感染通过诱导血管内皮细胞中整合素β3的表达促进肺血栓形成

Wataru Ito ,Yuya Sakurai ,Nako Maishi ,Ryo Takeda ,Takahito Teshirogi ,Li Yu ,Yasuhiro Hida ,Michihito Sasaki ,Yasuko Orba ,Takuya Tsumita ,Haruhisa Watanabe ,Tadahiro Iimura ,Terufumi Kubo ,Shinsuke Toba ,Akihiko Sato ,Aya Matsuda ,Daisuke Kyuno ,Makoto Osanai ,Yoichi Ohiro ,Toshihiko Torigoe ,Hirofumi Sawa ,Kyoko Hida

Repurposing of the RIPK1-Selective Benzo[1,4]oxazepin-4-one Scaffold for the Development of a Type III LIMK1/2 Inhibitor.

RIPK1 选择性苯并[1,4]氧氮杂环庚酮-4-酮骨架的再利用,用于开发 III 型 LIMK1/2 抑制剂

Mandel Sebastian, Hanke Thomas, Mathea Sebastian, Chatterjee Deep, Saraswati Hayuningbudi, Berger Benedict-Tilman, Schwalm Martin Peter, Yamamoto Satoshi, Tawada Michiko, Takagi Terufumi, Ahmed Mahmood, Röhm Sandra, Corrionero Ana, Alfonso Patricia, Baena Maria, Elson Lewis, Menge Amelie, Krämer Andreas, Pereira Raquel, Müller Susanne, Krause Daniela S, Knapp Stefan